300 related articles for article (PubMed ID: 22705708)
1. Assessment of genotoxic potential of Cr(VI) in the mouse duodenum: an in silico comparison with mutagenic and nonmutagenic carcinogens across tissues.
Thompson CM; Gregory Hixon J; Proctor DM; Haws LC; Suh M; Urban JD; Harris MA
Regul Toxicol Pharmacol; 2012 Oct; 64(1):68-76. PubMed ID: 22705708
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of the mode of action framework for mutagenic carcinogens case study II: chromium (VI).
McCarroll N; Keshava N; Chen J; Akerman G; Kligerman A; Rinde E
Environ Mol Mutagen; 2010 Mar; 51(2):89-111. PubMed ID: 19708067
[TBL] [Abstract][Full Text] [Related]
3. Synchrotron-based imaging of chromium and γ-H2AX immunostaining in the duodenum following repeated exposure to Cr(VI) in drinking water.
Thompson CM; Seiter J; Chappell MA; Tappero RV; Proctor DM; Suh M; Wolf JC; Haws LC; Vitale R; Mittal L; Kirman CR; Hays SM; Harris MA
Toxicol Sci; 2015 Jan; 143(1):16-25. PubMed ID: 25352572
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide gene expression effects in B6C3F1 mouse intestinal epithelia following 7 and 90days of exposure to hexavalent chromium in drinking water.
Kopec AK; Kim S; Forgacs AL; Zacharewski TR; Proctor DM; Harris MA; Haws LC; Thompson CM
Toxicol Appl Pharmacol; 2012 Feb; 259(1):13-26. PubMed ID: 22155349
[TBL] [Abstract][Full Text] [Related]
5. Comparative toxicogenomic analysis of oral Cr(VI) exposure effects in rat and mouse small intestinal epithelia.
Kopec AK; Thompson CM; Kim S; Forgacs AL; Zacharewski TR
Toxicol Appl Pharmacol; 2012 Jul; 262(2):124-38. PubMed ID: 22561333
[TBL] [Abstract][Full Text] [Related]
6. Comparison of in vivo genotoxic and carcinogenic potency to augment mode of action analysis: Case study with hexavalent chromium.
Thompson CM; Bichteler A; Rager JE; Suh M; Proctor DM; Haws LC; Harris MA
Mutat Res Genet Toxicol Environ Mutagen; 2016 Apr; 800-801():28-34. PubMed ID: 27085472
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures.
Proctor DM; Suh M; Campleman SL; Thompson CM
Toxicology; 2014 Nov; 325():160-79. PubMed ID: 25174529
[TBL] [Abstract][Full Text] [Related]
8. Tracing the tracks of genotoxicity by trivalent and hexavalent chromium in Drosophila melanogaster.
Mishra M; Sharma A; Negi MP; Dwivedi UN; Chowdhuri DK
Mutat Res; 2011 May; 722(1):44-51. PubMed ID: 21382505
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the mutagenic potential of hexavalent chromium in the duodenum of big blue® rats.
Thompson CM; Young RR; Dinesdurage H; Suh M; Harris MA; Rohr AC; Proctor DM
Toxicol Appl Pharmacol; 2017 Sep; 330():48-52. PubMed ID: 28687238
[TBL] [Abstract][Full Text] [Related]
10. Assessment of K-Ras mutant frequency and micronucleus incidence in the mouse duodenum following 90-days of exposure to Cr(VI) in drinking water.
O'Brien TJ; Ding H; Suh M; Thompson CM; Parsons BL; Harris MA; Winkelman WA; Wolf JC; Hixon JG; Schwartz AM; Myers MB; Haws LC; Proctor DM
Mutat Res; 2013 Jun; 754(1-2):15-21. PubMed ID: 23583686
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the mode of action underlying the tumorigenic response induced in B6C3F1 mice exposed orally to hexavalent chromium.
Thompson CM; Proctor DM; Haws LC; Hébert CD; Grimes SD; Shertzer HG; Kopec AK; Hixon JG; Zacharewski TR; Harris MA
Toxicol Sci; 2011 Sep; 123(1):58-70. PubMed ID: 21712504
[TBL] [Abstract][Full Text] [Related]
12. Duodenal crypt health following exposure to Cr(VI): Micronucleus scoring, γ-H2AX immunostaining, and synchrotron X-ray fluorescence microscopy.
Thompson CM; Wolf JC; Elbekai RH; Paranjpe MG; Seiter JM; Chappell MA; Tappero RV; Suh M; Proctor DM; Bichteler A; Haws LC; Harris MA
Mutat Res Genet Toxicol Environ Mutagen; 2015 Aug; 789-790():61-6. PubMed ID: 26232259
[TBL] [Abstract][Full Text] [Related]
13. Chromium(VI)-induced mutagenesis in the lungs of big blue transgenic mice.
Cheng L; Sonntag DM; de Boer J; Dixon K
J Environ Pathol Toxicol Oncol; 2000; 19(3):239-49. PubMed ID: 10983890
[TBL] [Abstract][Full Text] [Related]
14. Characterization of nonmutagenic Cr(III)-DNA interactions.
Blankert SA; Coryell VH; Picard BT; Wolf KK; Lomas RE; Stearns DM
Chem Res Toxicol; 2003 Jul; 16(7):847-54. PubMed ID: 12870887
[TBL] [Abstract][Full Text] [Related]
15. Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver.
Doktorova TY; Ellinger-Ziegelbauer H; Vinken M; Vanhaecke T; van Delft J; Kleinjans J; Ahr HJ; Rogiers V
Arch Toxicol; 2012 Sep; 86(9):1399-411. PubMed ID: 22484513
[TBL] [Abstract][Full Text] [Related]
16. Ten factors for considering the mode of action of Cr(VI)-induced gastrointestinal tumors in rodents.
Thompson CM; Suh M; Proctor DM; Haws LC; Harris MA
Mutat Res Genet Toxicol Environ Mutagen; 2017 Nov; 823():45-57. PubMed ID: 28985946
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the mutagenic potential of Cr(VI) in the oral mucosa of Big Blue® transgenic F344 rats.
Thompson CM; Young RR; Suh M; Dinesdurage HR; Elbekai RH; Harris MA; Rohr AC; Proctor DM
Environ Mol Mutagen; 2015 Aug; 56(7):621-8. PubMed ID: 26010270
[TBL] [Abstract][Full Text] [Related]
18. Chromium in drinking water: sources, metabolism, and cancer risks.
Zhitkovich A
Chem Res Toxicol; 2011 Oct; 24(10):1617-29. PubMed ID: 21766833
[TBL] [Abstract][Full Text] [Related]
19. Is hexavalent chromium carcinogenic via ingestion? A weight-of-evidence review.
Proctor DM; Otani JM; Finley BL; Paustenbach DJ; Bland JA; Speizer N; Sargent EV
J Toxicol Environ Health A; 2002 May; 65(10):701-46. PubMed ID: 12028825
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Toxicity and Recovery in the Duodenum of B6C3F1 Mice Following Treatment with Intestinal Carcinogens Captan, Folpet, and Hexavalent Chromium.
Thompson CM; Wolf JC; McCoy A; Suh M; Proctor DM; Kirman CR; Haws LC; Harris MA
Toxicol Pathol; 2017 Dec; 45(8):1091-1101. PubMed ID: 29161989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]